-
Access to Health Insurance Key to Disparities in Cancer OutcomesAs outcomes improved for cancer patients in states that expanded Medicaid, disparities in survival disappeared.
by Jon Kelvey
-
Second DCIS Diagnoses May Not Be Related to Initial LesionDNA sequencing found that in many cases when DCIS recurred, the lesion was unrelated to the first diagnosis, raising questions about how to best treat recurrence.
by Eric Fitzsimmons
-
Cracking the Code of Acute Myeloid LeukemiaTesting for chromosomal abnormalities and gene mutations helps to direct treatment for patients with AML.
by Kendall K. Morgan
-
Forward Look
Comparing Antibody-Drug Conjugates for Metastatic Breast CancerResults favor Enhertu for treating metastatic breast cancer that recurs or does not respond to first-line treatment.
by Kris Conner
-
Forward Look
What’s Next?Artificial intelligence may help to classify colorectal polyps.
by Nancy Averett
-
Get Involved
Doing Yoga in RecoveryA volunteer program brings yoga to cancer patients in the hospital.
by Bradley Jones
-
Q&A
The Certainty of UncertaintyAfter a stage IV cancer diagnosis, Kate Bowler publishes a second memoir that explores the precarious nature of her own mortality.
by Marci A. Landsmann
-
Forward Look
There’s Time to Consider Fertility Preservation OptionsWomen with breast cancer who choose fertility preservation have treatment outcomes similar to women who don't undergo fertility preservation.
by Kris Conner
-
Balancing Early-Stage Prostate Cancer DecisionsChoices about screening and treatment for early-stage prostate cancer are complex and largely personal.
by Kendall K. Morgan
-
Despite research linking fruits and vegetables to cancer survival, many people do not change their eating habits after diagnosis.
by Darlene Dobkowski
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood TestsAbout half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
-
Cancer in the Rearview Mirror: 15 Years of AACR Cancer Progress Report Survivor StoriesCancer survivors profiled over the past 15 years in the AACR Cancer Progress Reports shared updates on their lives and the progress made against cancer.
-
Pediatric Cancer’s AftershocksNew research highlights approaches that could provide better long-term quality of life for childhood cancer survivors.
Cancer Research at a Crossroads
